# RHA® Redensity With New Anesthetic Agent - Perioral Rhytids

> **NCT04069585** · NA · COMPLETED · sponsor: **Teoxane SA** · enrollment: 30 (actual)

## Conditions studied

- Aging
- Pain

## Interventions

- **DEVICE:** RHA® Redensity with new anesthetic agent
- **DEVICE:** RHA® Redensity with lidocaine

## Key facts

- **NCT ID:** NCT04069585
- **Lead sponsor:** Teoxane SA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-30
- **Primary completion:** 2020-02-24
- **Final completion:** 2020-11-09
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04069585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04069585, "RHA® Redensity With New Anesthetic Agent - Perioral Rhytids". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04069585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*